USCOM LIMITED — Investor Presentation 2009

Sep 16, 2009

==> picture [72 x 86] intentionally omitted <==

==> picture [353 x 218] intentionally omitted <==

USCOM (ASX: UCM) Broker Briefings SEPTEMBER 2009

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

USCOM – Summary

• Medical device Company with emerging “gold standard”

• heart monitor with multiple clinical applications

• 70% revenue growth last fin. year, cash flow break even in Q4 2009, and ready to rapidly grow sales through our US based global partner

• Further growth opportunities with development of

• additional markets and products

• GFC impact on end user hospital demand is uncertain,

• but early indications are for strong take-up

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Business Milestones

• Jan 2007 – Paul Butler appointed CEO, Daniel Fah appointed

• CFO, and Nick Schicht appointed General Manager

• New executive team proposed and implemented

• restructuring of business and new strategic US objectives • Operational restructure - cost reduced from $5.2m (FY07) to $3.1m (FY 09)

• Global marketing strategy - US focused marketing alliance

• July 2007 - CEO relocated to USA

• Dec 2008 - Agreement signed with Spacelabs Healthcare Inc.

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Strategic Partnership

Spacelabs Healthcare Developer, manufacturer and distributor of medical equipment and services:

• Spacelabs has exclusive distribution of the USCOM 1A in the Americas, Europe, Middle East, Africa, India, Australia (Medtel) for the in hospital market

OSI Systems Inc. (Parent of Spacelabs Healthcare .) Revenues $623m (FY09), Cap US$363m (FY09) Equity

• $600,000 ($0.30 per share) for 5% of Uscom Ltd

• Option to purchase additional 2m shares at $0.375

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

USCOM – Applications

Current applications – In Hospital market

• Sepsis

• Post cardiac surgery

• Nurse led CO measurement

• Anesthesia monitoring

• ED trauma resuscitation

• Liver transplantation

Unpartnered applications - New Markets

• Electrophysiology –potential partners such as Guidant, Medtronic or Saint Jude Medical

• • Heart failure

• Hypertension

• Drug/Medical research

• Organ procurement

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

USCOM – Investment

SPP

• Offer to existing shareholders to purchase up to $15,000 worth of shares at $0.63

• Looking to raise up to $1.26M

• As at 30 June 2009 Uscom had cash reserves of $1.9M

Use of Funds

• Increase our capability to support our global distribution partners

• Spacelabs Healthcare in North America, Latin America, Europe, Australia, Middle East and Africa

• Pacific Medical Systems in Asia

• o LEA Medizintechnik in Germany and Turkey o Develop partnership opportunities in Japan

• Develop market opportunity in;

o Electrophysiology sector o Heart failure o Hypertension

• Additional working capital

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Key Financial Achievements

==> picture [675 x 283] intentionally omitted <==

----- Start of picture text -----

$1,613k
$ -599
www.uscom.com.au The Measure of Life
----- End of picture text -----

==> picture [72 x 86] intentionally omitted <==

www.uscom.com.au

==> picture [382 x 28] intentionally omitted <==

----- Start of picture text -----

Key Financial Achievements
----- End of picture text -----

==> picture [252 x 23] intentionally omitted <==

----- Start of picture text -----

The Measure of Life
----- End of picture text -----

==> picture [72 x 86] intentionally omitted <==

==> picture [382 x 28] intentionally omitted <==

----- Start of picture text -----

Key Financial Achievements
----- End of picture text -----

==> picture [675 x 24] intentionally omitted <==

----- Start of picture text -----

www.uscom.com.au The Measure of Life
----- End of picture text -----

==> picture [72 x 86] intentionally omitted <==

==> picture [399 x 28] intentionally omitted <==

----- Start of picture text -----

Primary product – USCOM 1A
----- End of picture text -----

==> picture [248 x 335] intentionally omitted <==

www.uscom.com.au

==> picture [176 x 335] intentionally omitted <==

==> picture [141 x 335] intentionally omitted <==

==> picture [252 x 23] intentionally omitted <==

----- Start of picture text -----

The Measure of Life
----- End of picture text -----

==> picture [72 x 86] intentionally omitted <==

USCOM – Standard of Care

Fluid - “The change in SV with PLR was the only haemodynamic index with significant predictive ability” 91% +ve predictive value. Critical Care 2009;13:R111

ICU/PAC – “ USCOM.. may safely replace PAC in many clinical situations that call for advanced hemodynamic monitoring.” Am J Surgery 2008:196(Dec);961-968

Pediatric Sepsis – “Subsequent haemodynamic support directed to goals of …… cardiac index of 3.3-6.6l/min/m[2] ” Crit Care Med 2009;37:666-688

Organ Procurement– 15% increase in organs for transplantation using USCOM optimisation compared to BP and CVP. Chest 2008; 134(Abst): s21003

Liver Transplantation - Editorial questioning the use of PAC after publication of studies suggesting replacement by USCOM in Liver Transplantation. Liver Transpl 2008;14:917-918

Pacemakers- “USCOM device operated by trained nurse can provide a simple, accurate, and fast non- invasive method for the AVI optimization in CRT.” PACE 2007 30;1: 50–55.

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Emerging standard of care

135 peer reviewed publications and presentations 17 Papers and 29 articles, abstracts and posters FY09

==> picture [109 x 141] intentionally omitted <==

==> picture [106 x 140] intentionally omitted <==

==> picture [109 x 141] intentionally omitted <==

==> picture [110 x 141] intentionally omitted <==

==> picture [109 x 136] intentionally omitted <==

==> picture [104 x 138] intentionally omitted <==

==> picture [102 x 138] intentionally omitted <==

==> picture [101 x 140] intentionally omitted <==

Emergency, Pediatrics, Cardiac transplantation, Electrophysiology, Heart Failure, Emergency transport, Anesthesia, Liver transplantation, ICU, Septic shock, Pre-eclampsia, Pulmonary hypertension, Nurse outreach, Organ procurement, Haemodialysis, Neonates, infants, Children etc……..

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

IP - Adding value

USCOM has significant value in patent protected IP

24 patent applications 18 granted patents 11 different applications 2 new US patents since June 2008 Peter Treloar, Patent Attorney, Uscom Patent Report Building a product pipeline….

==> picture [66 x 7] intentionally omitted <==

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Share price 09

				Spacelabs partnership	Spacelabs partnership
	FY	Share Price	Revenue		Cap value
	2008	0.18	$0.984m		$6.84m
	2009	0.77	$1.630m		$30.8m
www.uscom.com.au			The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Market Performance

==> picture [223 x 27] intentionally omitted <==

==> picture [522 x 305] intentionally omitted <==

PWC BioForum Ed. 29 Q4 FY2009 www.uscom.com.au The Measure of Life

==> picture [72 x 86] intentionally omitted <==

Equity Structure

==> picture [675 x 316] intentionally omitted <==

----- Start of picture text -----

|||
|---|---|
|Listed:|Dec 2003 (ASX Code: UCM)|
|Total Issued shares:|40,000,000|
|SPP Maximum issue:|2,000,000|
|Top 5 shareholders:|70% of shares|
|ROBERT ALLAN PHILLIPS|16,590,000|
|GARY DESMOND DAVEY|6,000,000|
|BELL POTTER NOMINEES LTD |2,124,836|
|OSI SYSTEMS|2,000,000|
|DRP CARTONS (NSW) PTY LTD |1,248,730|
|www.uscom.com.au|The Measure of Life|

----- End of picture text -----

==> picture [72 x 86] intentionally omitted <==

USCOM – Summary

• Medical device Company with emerging “gold standard”

• heart monitor with multiple clinical applications

• 70% revenue growth last fin. year, cash flow break even in Q4 2009, and ready to rapidly grow sales through our US based global partner

• Further growth opportunities with development of

• additional markets and products

• GFC impact on end user hospital demand is uncertain,

• but early indications are for strong take-up

www.uscom.com.au

The Measure of Life

==> picture [72 x 86] intentionally omitted <==

==> picture [486 x 301] intentionally omitted <==

www.uscom.com.au The Measure of Life